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CHAPTER 1. GENERAL INTRODUCTION 
INTRODUCTION 
A major problem in biology is the storage and retrieval of biological data in a 
meaningful and efficient manner. With the advent of mass sequencing projects, such as the 
human genome project, the need to store, retrieve, and analyze sequence data is stronger than 
ever before. The following thesis tackles a small part of this problem by presenting 
techniques, models, and applications for productively storing and retrieving a set of related 
viral sequences in a central data bank. The thesis begins by providing an overview of the 
relational database and its role in storing biological data. The main chapter of the thesis is a 
description of a novel relational database application (EIAV DB). EIAV DB is a central 
repository of equine infectious anemia virus (EIAV) sequence and feature information. The 
models and application provide insight into technologies that help alleviate the storage and 
retrieval problem. 
THESIS ORGANIZATION 
Chapter 1 gives a short introduction to the thesis. 
Chapter 2 gives the background of relational databases and their use in biology. 
Chapter 3 gives a background on retroviruses and equine infectious anemia virus, 
paying particular attention to studies that produce the types of information to be stored in the 
database. It also describes the complexity of the viral data, demonstrating a need for the 
efficient storage of this data. 
Chapter 4 gives an application of relational databases with biological data. It 
describes the EIAV DB, a relational database composed of EIAV sequence and 
accompanying data. 
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Chapter 5 provides conclusions drawn from the work in the thesis and suggests 
possible directions for EIAv DB. 
References for each chapter are placed at the end of that chapter. 
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CHAPTER 2. BACKGROUND ON RELATIONAL DATABASES & 
THEIR USE IN BIOLOGY 
RELATIONAL DATABASE BACKGROUND 
Database management systems were revolutionized in 1970 when Ted Codd wrote a 
paper entitled "A Relational Model of Data for Large Shared Data Banks [3]." The paper 
forever changed the way that data are stored and retrieved by introducing a view of data 
organized as tables called `relations' . Codd argued that the relational model was superior to 
previous models such as the graph and network models. The first of several advantages that 
the model possesses is that it is able to describe data in its natural form without disrupting it 
with additional organization for machine representation purposes. Also, it is able to handle 
derivability (the ability to be traced), eliminate redundancy (the needless repetition of 
attributes), and enforce consistency (the harmonious uniformity of things or parts). Finally, 
an important historical note, the relational view permitted a framework for more accurately 
assessing the scope and logical constraints of previously formatted data systems [3] . 
RELATIONAL DATABASE USE IN BIOLOGY 
In the last few years, a task confronting many biologists is the modeling, storage, and 
retrieval of biological data. For the most part, researchers have relied on text file systems to 
store their data. This mode of storage can be inefficient and redundant, especially for large 
and complex biological datasets. In Bergholz et al. [ 1 ], a model using relational database 
technology to store biological sequence data is presented. Bergholz proposes that data 
should first be modeled using an entity-relationship approach (Figure 1), a model introduced 
by Chen et al. [2] in 1976. The construction of the entity-relationship model is an 
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intermediate step that occurs before construction of the relational model. It operates by 
representing semantic information or meaning about the `real world' . It embraces the belief 
that the `real world' is composed of entities, or physical objects, and the relationships that 
connect these entities [2J. Entities are a collection of attributes, or objects, that characterize 
an entity. For example, in Figure 1, employee and department entities are related through the 
dept-emp relationship and a l:N relationship classification, meaning that an employee can be 
in only one department, whereas, a department may contain several employees. Teorey et al. 
[4] extended the entitiy-relationship model in 1986, with the extended entity-relationship 
model. The extended model includes semantics for optional relationships, which occur when 
an entity need not exist, ternary relationships which occur when the association of three 
entities cannot be represented by several binary relationships among those entities, and sub 
typing, which is the classification of entities which share common attributes. 
Figure 2 illustrates how the extended entity-relationship approach proved to be 
friendlier to users of larger database systems who would often ignore the entity-relationship 
model due to its complexity in terms of their data [4] . For example, a ternary relationship is 
displayed between the entities: employee, project, and location. This indicates that 
employees can be assigned to one or more projects, but can only be assigned to one project at 
a given location. 
Bergholz et al. argues that using the entity-relationship model for DNA and protein 
data leads to a `clean' design, i.e. a design without redundancies [ 1 ] . The author shows how 
data found in sources like EMBL, SWISS-PROT, and Genbank can be extracted and stored 
in a way that is more meaningful than their native, text form. They assert that the first step in 
constructing a relational database is to find an appropriate model for the targeted data. Using 
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the entity-relationship techniques developed by Chen and extended by Teorey provides a 
natural mechanism for constructing this model. Next, a simple transformation from the 
entity-relationship model to the relational model is required. Creating a table for each entity 
and representing each entity attribute with a column in the table easily accomplishes this 
conversion. Finally, the database can be implemented using a relational database 
management system such as Sybase or Mysql [ 1 ]. 
By integrating the entity-relationship model, the relational model, and relational 
database management systems, Bergholz et al. established a robust foundation for biological 
data storage and retrieval. This foundation has already lead to successful biological data 
storage, such as the Biological Sequences Integrated database [1]. This database helps 
answer biological questions by forming an integrated information management system that 
interconnects molecular biology databases and analysis tools [ 1 ]. It is expected that the 
marriage of these three components and its application to biological data storage will persist 
for some time. 
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Figure 1. Illustration of an entity-relationship model for a manufacturing firm. The entities 
are represented by rectangles. The relationships are represented by diamond shaped figures. 
The relationships are further described in 1:1, 1: n (n = 0, 1, 2, ...) ,and m: n (m = 0, 1, 2, ... n 
= 0, 1, 2, ...)mappings. Entities which are surrounded by a double rectangle box are known 
as being dependent on the corresponding entity. For example, the entity DEPENDENT 
depends on the EMPLOYEE entity. [Unmodified figure 11 from Chen et al., 1976 [2]] 
Figure 2. Illustration of the extended entity-relationship Model. It represents a company 
personnel and project database. It also illustrates the three semantics (optional relationships, 
ternary relationships, and subtyping) that were extended from the entity-relationship model. 
Optional relationships are demonstrated with a "O" on the line that connects two entities. 
For example, the optional relationships between ENGINEER and PRF-ASSOC indicate that 
an engineer can be apart of many professional associations or none at all, or that professional 
organizations can have many members that are engineers or none at all. Ternary 
relationships are indicated by three entities that are connected by a triangular symbol that 
may have shaded corners (indicating many) or unshaded corners (indicating one). So, the 
ternary relationship between the entities skills, projects, and location can be described as 
employees at several locations are assigned to a project. Subtyping is evident when two or 
more entities point to a common attribute. For example, the entities manager, engineer, 
technician, and secretary are represented by the employee entity. [Unmodified figure 7 from 
Teorey et al., 1986 [4] ] 
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CHAPTER 3. BACKGROUND AND BIOLOGY OF EIAV 
RETROVIRUSES AND LENTIVIRUSES 
Retroviruses were discovered in 1970 by Temin et al. [16] and Baltimore et al. [2]. 
Working independently, the two groups were able to make the finding through different 
modes of study. Temin was embarking on the question of how RNA-containing viruses 
could lastingly alter the heredity of cells, while Baltimore was studying virion-associated 
polymerases. Through their research both found that retroviruses contain an RNA-dependent 
DNA polymerase [2,16]. The hallmark of retroviruses is that they are composed of single 
stranded RNA molecules that are usually 7 to 12 kb long, nonsegmented, and of positive 
polarity. The virus uses reverse transcriptase to make a linear double-stranded DNA 
molecule. It then inserts this DNA into the host genome from where it directs the production 
of the next generation of viruses. 
The lentivirus subgroup of retroviruses was discovered in 1904 when the equine 
infectious anemia virus (EIAV) was identified, though this was before the official 
classification of retroviruses [9]. EIAV was coincidently also one of the first viruses to be 
found in nature [9]. The members of the lentivirus subgroup are associated with long 
incubation periods, which have earned them the name `slow viruses' [9]. They are also 
known to cause immune deficiencies, blood disorders, and nervous system disorders. 
Lentiviruses have a complex genome organization, tropism for cells of the 
monocyte/macrophage lineage, and the tendency to establish persistent, life-long infections 
[3]. In addition to the pol, gag, and env genes, which are found in all retroviruses, 
lentiviruses contain several other regulatory genes such as tat and rev [9]. The life cycle of 
retroviruses is complex and involves several proteins. The cycle begins with the binding of 
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retroviral particles to the membrane of the host cell membrane, via an interaction between the 
cellular receptor and viral surface protein. The fusion of the viral envelope with the cellular 
plasma membrane allows the viral core to enter into the infected cell. Upon entry into the 
cell the envelope of the particle is lost, along with the viral capsid. At this point the 
retroviral genome uses reverse transcriptase to create adouble-stranded DNA copy of the 
genome of the virus that is integrated (using integrase enzyme) into the chromosome of the 
host cell. Transcription is used by the host cell's RNA polymerase to make several mRNA 
copies. Translation follows which yields the Gag, Env, and Pol proteins. A capsid protein 
later forms an mRNA/RTase complex. Finally, the infected cell releases virions by a process 
known as budding that enables the infection of other cells, allowing the cycle to continue. 
Rev is one of the proteins that is involved in the retroviral life cycle. It is one of 
the proteins required for the production of the viral structural proteins of the virus [3]. It aids 
the nuclear export of the incompletely spliced viral RNA's during the late phase of virus 
replication. These viral RNA's encode the structural proteins and serve as progeny RNA 
molecules [3]. The gag gene encodes the internal structural Gag protein of the virus. Gag is 
proteolytically processed into the mature proteins MA (matrix), CA (capsid), NC 
(nucleocapsid), and sometimes others [6]. The Gag protein is crucial for the budding of 
retroviruses from host cells and is cleaved upon virion maturation [2]. 
The pol gene encodes the reverse transcriptase enzyme (RT), which contains both 
DNA polymerase and associated Rnase H activities, and integrase (IN), which mediates 
replication of the genome [6]. The env gene encodes the surface (SU) glycoprotein and the 
transmembrane (TM) protein of the virion. They form a complex that interacts specifically 
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with cellular receptor proteins. This interaction leads ultimately to the fusion of the viral 
membrane with the cell membrane [6] . Genetic variation in the surface proteins can alter cell 
tropism and has been shown to be an important mechanism of immune evasion [3]. The LTR 
regions of the genome are equivalent sequences that are composed of three elements: U3, R, 
and US [6] . The region contains the signals required for retroviral RNA synthesis and 
processing [7]. 
One of the defining characteristics of retroviruses is their extraordinarily high genetic 
diversity. This genetic diversity is the result of the high error rate of reverse transcriptase 
and promotion of frequent recombination by reverse transcriptase. Recombination occurs 
when a cell is simultaneously infected by two different proviruses, which is a viral genome 
that has become part of chromosomal DNA of the host cell. This allows the combination of 
one RNA transcript from each provirus into a heterozygous virion. After the subsequent 
infection of a new cell, the reverse transcriptase enzyme moves back and forth between the 
two RNA templates. This creates a newly synthesized retroviral DNA sequence that is a 
recombinant of the two parental genomes [ 14] . The result of these mutation and 
recombination events is a population of similar, yet nonidentical, viral genomes referred to as 
a viral quasispecies. The quasispecies is characterized by continuous genetic variation, 
competition, and selection [8]. 
EIAV BIOLOGY 
Equine infectious anemia virus (EIAV) shares some common features with other 
lentiviruses [3]. Most lentivirus infections are characterized by a gradual, chronic disease 
state, but infection of horses with EIAV usually results into a dynamic disease course 
characterized by numerous cycles of viremia, fever, thrombocytopenia, potential anemia, and 
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depression [3,12] . There are three clinical categories of EIAV infection: acute, chronic, and 
inapparent. The acute stage occurs about three days after infection and usually last 3 to 5 
days [ 12]. The acute stage is often followed by the chronic stage, in which the infected horse 
experiences about six to eight disease episodes that repeat at inconstant intervals [ 12] . Fever 
cycles are typically irregular and may recur for up to one year, despite the onset of a 
neutralizing-antibody response [3]. The inapparent stage usually starts 6 - 12 months after 
infection. It is characterized by an ill-defined period of clinical dormancy. Because horses 
that survive these initial clinical episodes become life-long, inapparent carriers, EIAV 
infection is an excellent model for studies of virus and host factors that contribute to 
lentivirus persistence and pathogenesis [3]. 
EIAV has a relatively small genome (8,249 nucleotides). It is composed of the six 
genes tat, gag, pol, s2, env, and rev (Figure 1) and two LTR regions, one at each end of the 
retroviral DNA. They all have various functions, except s2, whose function remains 
unknown [17]. 
EIAV has several regions of variability including the LTRs, env gene, and the rev 
region. The LTRs are the most variable regions of the EIAV genome. Sequence variability 
in this region has been found to be important for the onset of severe acute disease. 
Variability in the LTR's and env gene regions are known to produce viruses with virulent 
phenotypes [ 13]. It was also found that variability in the rev region during long standing 
infection has an impact on long term viral persisitence [3,4] . Abetter understanding of the 
impact of genetic variablility in the EIAV genome on viral replication, virulence, and 
persistence, and a mode of storing this information would be beneficial to EIAV researchers. 
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VIRAL GENOME DATA AND RETROVIRAL DATABASES 
In 2001, it was estimated that no less than 52°Io of completely sequenced genomes 
and organelle sequences where from viral genomes. Within Genbank, the virus subdivision 
had 669 complete viral genomes and 130,083 distinct viral entries representing 114,600,849 
base pairs of sequence. When examining the number of species that had some of their 
genomic sequence determined, viruses contributed 5472 distinct species, 12% of which had a 
complete genomic sequence [ 10, 5]. Currently, there are 1,274 viral genomes and 79 
completely sequenced retroviral genomes stored in Genbank [5 ] . 
With the large number of viral species that have been sequenced, the need for 
centralized databases is more important now than ever [ 10] . Two of the more popular 
retrovirus databases are the HIV Sequence Database and the HIV RT/Protease Sequence 
Database. The HIV Sequence Database is based at Los Alamos and is composed of all 
published sequences and their accompanying annotations. It also contains several tools for 
the analysis of the sequence data. The Protease and RT Database is based at Stanford 
University and is composed of sequences associated with the development of viral resistance 
to anti-retroviral drugs. It focuses on the analysis of those sequences that confer resistance 
[ 11 ] . These databases were created to help researchers deal with the large amount of 
sequence variability in the virus. They have aided in the development of anti-viral drugs and 
vaccines, and helped form a better understanding of biology, immunology, and evolution of 
other pathogens [ 11 ] . 
Genbank contains a wealth of information about EIAV, including sequences 
sampled at multiple times from the same host [3], sequences sampled from transmission-
related but distinct hosts [ 1 ], sequences from natural infections [ 15], and derivatives of 
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standard lab strains. However, there is much information that is not stored in Genbank, such 
as viral load, temperature, and other clinical information. A database that stores information 
from Genbank and supplementary information from other sources would facilitate 
metastudies that combine these data to advance our understanding of EIAV evolution. For 
example, it has been found that the virus is highly mutagenic and produces populations of 
viruses within the host that change and shift over time [3]. This temporal genetic variation is 
common in lentiviruses and makes it difficult to create effective vaccines [ 1 ] . Not only are 
researchers interested in the evolution of the virus over time in the same host, but also how 
the virus interacts with and changes in response to different host immune systems. For 
example, researchers may compare the clinical symptoms of ponies infected with the same 
serum stock. Finally, sequences collected from otherwise independent sources provide 
information about natural genetic variation in EIAV and its association with host type, mode 
of infection, genomic regions, or geographic location. The previous examples show the great 
potential of a centralized EIAV database, but highlight some of the difficulties with the 
current reliance on Genbank. Finding the relationships between sequences in Genbank is 
inefficient if not impossible. A centralized database that stores sequence relationships and 
permits complex queries involving these relationships will help revolutionize EIAV research. 
EIAV DB is an on-line relational database that serves as a central repository for 
EIAV sequences from across the world. It was built to overcome some of the shortcomings 
of sequence databases such as Genbank and local files of EIAV researchers. A major 
advantage that the database has is the ability to integrate clinical information and sequence 
information on a host over multiple timepoints. Other advantages of EIAV DB includes its 
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ability to record relations among sequences and epidemiological relationships, and its ability 
to perform novel queries in a quick and efficient way. 
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CHAPTER 4. APPLICATION OF RELATIONAL DATABASE DESIGN 
AND USE IN THE EIAV RESEARCH: EIAV DB 
A paper to be submitted to Applied Bioinformatics 
LaRon M. Hughes, Susan Carpenter, and Karin S. Dorman 
ABSTRACT 
EIAV DB is an on-line relational database that serves as a central repository for 
equine infectious anemia virus (EIAV) sequences collected by researchers across the world. 
The database contains a compilation of sequences from Genbank, unpublished reports, and 
published reports. The entity-relationship model was used to construct the data model. The 
database was designed to allow further growth. The user interface was constructed with the 
primary goal of permitting complex data searches. It has the ability to integrate sequence 
data with host information and disease state as well as record known relations among 
sequences and hosts, and perform novel queries. 
INTRODUCTION 
With the large number of viral species that have been sequenced, the need for 
centralized databases is more important now than ever [5]. In particular, highly variable 
viruses pose a unique set of difficulties for large public databases such as Genbank. Because 
the genomic variability is of interest to researchers, these viruses are sequenced repeatedly. 
For example, there are now 370 full-length and 99,700 partial HN-1 sequences in Genbank 
[6]. The complex relationships among these sequences and connections to available host 
information are infinitely valuable for meaningful research but generally unavailable in the 
central repositories. This information is split between sequence databases, the literature, and 
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`walking' expert systems. Data mining under these conditions is slow and extremely labor-
intensive [5 ] . The collection of these data into centralized, comprehensive, and extensible 
viral databases would be a significant and substantial contribution of bioinformatics to virus-
related research. Here we describe a relational database system to store viral and host data 
for the highly variable pathogen, equine infectious anemia virus, a relative of the human 
immunodeficiency virus. 
EIAV BACKGROUND 
Equine infectious anemia virus (EIAV) is a member of the lentivirus subfamily of 
retroviruses. It has common features with other lentiviruses, such as a complex genome 
organization, tropism for cells of the monocyte/macrophage lineage, and the tendency to 
establish persistent, life-long infections. While most lentivirus infections are characterized 
by a slow, chronic disease state, EIAV infection can result in a dynamic disease course 
characterized by recurring cycles of viremia, fever, thrombocytopenia, and possible anemia. 
Fever cycles are typically irregular and may recur for up to one year, despite the onset of a 
neutralizing-antibody response. Horses that survive these initial clinical episodes become 
life-long, inapparent carriers. EIAV infection is an excellent model for studies of virus and 
host factors that contribute to lentivirus persistence and pathogenesis. 
Like other retroviruses, EIAV is a highly diverse virus. At all points during an 
infection, there are typically several variants present within the infected horse, with most of 
the variability residing in the LTR, rev, and surface envelope regions of the genome [3]. As 
for any virus, the virus spreads by transmission between hosts, though EIAV and its equine 
hosts have also been used as an animal model system with some experimental infections 
from stock virus [3]. Because of these factors, any subset of EIAV sequences present in 
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Genbank is far from a random sample of the global population of EIAV. Instead, they may 
come from the same blood sample [ 1 ], the same infected horse [3], the same localized 
outbreak [ 8 ] , or the same in vitro lab experiment [7 ] . 
The persistence of EIAV and other lentiviruses is thought to be the outcome of a 
lengthy battle between a constantly evolving virus and a continually adapting host immune 
system. This antagonistic relationship ultimately promotes the survival of the virus because 
it increases the likelihood of it being transmitted to another host. Since understanding the 
nature of this interaction is a primary goal of lentivirus research, it is imperative that 
available host immune information be publicly accessible and linked to the corresponding 
viral data. 
EIAV DB DATABASE 
DATA MODEL 
Following Bergholz et al., the EIAV DB database was first designed in terms of the 
entity-relationship model (Figure 2) [4] . We identified four entities in the data: sequence, 
timepoint, source, and feature. The sequence entity represents the result of a single sequence 
read, possibly corrected for read errors, and is composed of single value attributes associated 
with the sequence, such as the accession number and actual nucleotide sequence. The source 
entity represents a physical source of experimental data. Usually, the source is an infected 
source or pony, but may also represent an experiment or set of experiments that produced a 
collection of data. The timepoint entity represents one sample point collected from a source 
entity. For example, each blood sample collected from an infected horse is represented by a 
single timepoint. The feature entity represents a biological feature found within a sequence, 
cataloging, for example, a gene or a binding site found in a sequence. 
Zo 
In the entity-relationship model, entities are related to each other in various ways. 
Included in Figure 1 is a representation of the connectivity that is used to describe the 
relationship classification (e.g., one-to-one (1:1), one-to-many (L•M), and many-to-many 
(M:N)). The sequence entity is linked to the timepoint entity by an OCCURS_IN relationship 
indicating that sequences are sampled from particular timepoints. This relationship is many- 
to-many because a particular sequence may be sampled from several distinct timepoints and 
one timepoint usually contains multiple sequences. Features are linked to sequences through 
the FEATURED_BY relationship indicating that features are contained in a sequence. The 
FEATURED_BY relationship is also many-to-many indicating that there is typically more 
than one feature associated with each sequence, and more than one sequence producing the 
same feature, for example the same amino acid sequence. The timepoint entity is linked to 
the source entity through the OCCURS_IN relationship and amany-to-one connection 
indicating that there are multiple timepoints contained within a source. 
DATABASE DESIGN 
The schema of the EIAV DB database is illustrated in Figure 3. There are a total of 
seven tables (see Table 1) in the EIAV DB database representing the four entities and 
relationships. The tables map to the corresponding entities defined in the entity-relationship 
model. The feature coordinates table represents the M:N link between the sequence and 
feature tables. It contains specific attributes about a feature found in a particular sequence, 
such as the start and finish of the feature relative to the first nucleotide in the sequence and 
researcher-defined nomenclature. The timepoint sequence link table links the sequence 
entities to their sampling timepoint(s) and indicates the number of times each unique 
sequence was sampled from that timepoint. The feature summary table summarizes how 
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many total features and unique features were sampled from a given timepoint or source. This 
information is computable from the other tables, but requires multiple queries. 
EIAv DB is implemented using Mysgl on a Linux platform. The data from the 
database are made available over the web using an Apache server running Perl CGI scripts. 
The database is accessible using Netscape versions 4.0 and above and Internet Explorer 
version 5.0 and above; it is likely that most HTML 2.0 and JavaScript compliant browsers 
can also be used. 
DATABASE CONTENTS 
As of July of 2004, the database contained a total of 1019 distinct sequences from 
several ponies and time points. Based on features or genes there were a total of 493 rev gene 
sequences, 286 env gene sequences, 56 gag gene sequence, 29 tat gene sequences, 24 pol 
gene sequences, no s2 gene sequences, and no long terminal repeat (LTR) sequences. Most 
of the sequences had Genbank accession number. 
DATABASE SEARCH INTERFACE 
The user interface provides query and submission functions with ease-of-use and 
openness in mind. The database search web page is divided into four searching categories 
(Sequence Information, Sequence Feature Information, Clinical Information, and Infection or 
Experimental Information). A search on Sequence Information allows for restrictions on the 
types of sequence information that are returned; e.g. a search that returns sequences that are 
of a minimal length. A Clinical Information search returns information about horses with 
specific clinical symptoms or that fall into precise clinical categories; e.g. sequences isolated 
from horses during specific febrile episodes. A search on Sequence Feature Information 
allows for a search on sequences with particular genetic or phenotypic features; e.g. find all 
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sequences with the Rev phenotype above a certain threshold. Finally, a search on Infection 
or Experimental Information allows for a search on data about the infecting source or from 
specific kinds of experiments or infections; e.g. extract all sequences identified as the pony 
524 who were experimentally infected with stock innoculum. 
The buttons at the top of the interface page allow users to retrieve information based 
on four categories: sequences, features, clinical data, and data sources. Though it is possible 
to select the same inputs, each category has a different emphasis on the type of information 
that is returned. 
EIAV DB PROMOTES FURTHER EXTENSION AND GROWTH 
An advantage of using a relational database management system is that creating a 
new column or table in the existing database scheme may easily incorporate additional entity 
attributes or entities, respectively. For example, the discovery of EIAV subclasses (e.g. 
subtypes or genotypes) could be accommodated by adding a new "subtype" field in the 
sequence table. 
EIAV DB INTEGRATES SEQUENCE DATA WITH HOST INFORMATION AND DISEASE STATE 
Information about the host state at the time of sequence sampling (antibody titer, viral 
load, temperature, etc.) is included in the database. By integrating this information into the 
database structure, it is now possible to perform complex queries that facilitate research 
regarding epidemiology, host-pathogen interactions, and more. For example, observations of 
host-pathogen interactions are possible by querying on different levels of clinical 
information, like a viral load range between three and seven, and noting the reaction of a 
particular pony through its clinical symptoms, say the platelet count or temperature. 
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EIAV DB RECORDS KNOWN RELATIONS AMONG SEQUENCES AND EPIDEMIOLOGICAL 
RELATIONSHIPS 
The EIAV DB holds information about the relatedness of sequences. These 
relationships result from evolution within the same host, cell passage, or host-to-host 
transmission. If origin information about a group of related sequences is available and they 
are inserted into the database, it is possible to connect these sequences and form 
epidemiological relationships. For example, the database records (Figure 4) that ponies 524 
and 618 were infected by a serum inoculum of the highly virulent Wyoming strain of EIAV . 
Pony 625 was subsequently infected with a serum inoculum, obtained from a sample taken 
from pony 524 at 878 days post infection. Such queries offer valuable information to 
researchers. 
NOVEL QUERIES 
With EIAV DB, there are several questions that can be answered regarding EIAV that 
previously could not be answered in a quick and efficient way. For example, based on a 
query that displays the temperature and platelet count for several ponies, there is found to be 
a significant (p-value of 4E-08) difference between those platelet count values that occur 
during a febrile period (> 100 °F) and those that occur during afebrile periods. Platelet count 
values are significantly lower during febrile periods. 
SUMMARY 
A central repository for EIAV sequences around the world has been presented. Now, 
quick and efficient queries are possible that were not possible before. EIAV DB is a valuable 
tool that EIAV and other virology researchers should find useful. 
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FUTURE WORK 
During the next few years, the database is expected to grow in several directions. The 
first expansion will involve filling in gaps of information that were lost in the transfer from 
Genbank, sequence information from published articles, and researchers who have 
information stored in local disk. Secondly, based on the needs and requests of researchers 
the database schema will expand to include new EIAV data. For example, the discovery of 
EIAV subclasses (e.g. subtypes or genotypes) could be accommodated by adding a new 
"subtype" field. Finally, the web interface could additionally interconnect the database with 
other biological databases, such as Genbank, as well as sequence analysis programs, like 
PAQ [2]. 
AVAILABILITY 
EIAV DB is accessible at the URL http://vito.zool.iastate.edu/Aaron/perl/interface.pl.
Inquiries concerning the database should be directed by email to kdorman @ iastate.edu. 
CITING THE DATABASE 
Please refer to this article when quoting the EIAV DB sequence database. 
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Table 1. List of tables for EIAV DB 
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Figure 4. The following shows the result of a database query for detailed information about 
Pony 625. Demonstrated is the ability of EIAV DB to display epidemiological relationships 
between ponies. Here, it is shown that pony 625 was infected with an experimental-serum 
from the 878th day post infection (dpi) of pony 524. 
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CHAPTER 4. GENERAL CONCLUSIONS 
SUMMARY 
In this thesis, a small part of the storage and retrieval of biological data problem was 
tackled. The thesis began by providing an overview of the relational databases and their use 
in biology. It then gave a backgound on retroviruses and equine infectious anemia virus 
(EIAV). The main focus is on EIAV DB, an on-line relational database that serves as a 
central repository for EIAV sequences collected by researchers across the world. The models 
and applications in this thesis provide insight into technologies that help alleviate the storage 
and retrieval problem. 
FUTURE WORK 
During the next few years, the database is expected to grow in several directions. The 
first expansion will involve filling in gaps of information that were lost in the transfer from 
Genbank, sequence information from published articles, and researchers who have 
information stored in local disk. Secondly, based on the needs and requests of researchers 
the database schema will expand to include new EIAV data. Finally, the web interface could 
additionally interconnect the database with other biological databases, such as Genbank. 
